Impilo becomes second largest shareholder in Humana
The Swedish investment company Impilo has entered into an agreement to acquire the equivalent of 12.5 percent of the shares in Swedish care company Humana AB (publ) (”Humana”) from Humana’s largest shareholder, Argan Capital. Through this investment, Impilo becomes the second largest shareholder in Humana and intends to contribute actively in the continued development of the company.
Humana was founded in 2001 and is a leading provider of care services in the Nordic region, currently with c. 15,000 employees and a turnover of SEK 6.6bn. Humana is the market leader within Individual & Family care services as well as Personal Assistance in Sweden, the second largest provider of Individual & Family care services in Norway and Finland, and is also present in Denmark through an acquisition made late 2018. Today, the company serves about 8,000 clients in these countries.
Impilo focuses exclusively on investments in Nordic healthcare companies active in the areas of pharmaceuticals, medical technology, healthcare services and other health-related areas. The objective is for the portfolio companies to contribute to the development and improvement of their respective areas and thus contribute to a sustainable society in the longer term. The care markets in the Nordics are facing significant opportunities and challenges, and Humana’s strong focus on high quality, satisfied customers and continued growth contributed to Impilo identifying the company as an attractive investment opportunity early on.
”The care sector is central in creating a functioning welfare system in the Nordic region. Thanks to our exclusive focus on the healthcare sector and experience from developing growing companies, we believe we can support Humana over the long term in developing and establishing an even stronger platform for delivering these services with high quality and efficiency”, says Fredrik Strömholm, Partner at Impilo.
”Humana’s position in the Nordic care markets, with its focus on making care available to everyone who needs and deserves it, is very much aligned with Impilo’s view on what will be required to build a sustainable and successful position. We are very pleased to get the opportunity to work together with the company in driving the future development of the Nordic care sector”, continues Veronica Byfield Sköld, Partner at Impilo.
For further information, please contact:
Fredrik Strömholm, Partner at Impilo AB
+46 76 115 10 65
fredrik.stromholm@impilo.se
Veronica Byfield Sköld, Partner at Impilo AB
+46 730 733 933
veronica.skold@impilo.se
About Impilo
Impilo is a Swedish investment company focused on investments in Nordic healthcare companies active in pharmaceuticals, medical technology, healthcare services and other health-related areas. Impilo's perspective is that the portfolio companies must contribute to a positive development in their fields and thus society in order to be successful long term. Impilo manages over SEK 3.5 billion in capital from leading Nordic and international investors. Larger investors include AP3 (The Third Swedish National Pension Fund), TryghedsGruppen and Goldman Sachs Asset Management. Learn more about Impilo at www.impilo.se.
About Humana
Humana is a leading Nordic care company that offers individual and family care services, personal assistance, elderly care and special services housing under LSS (the Swedish Act Concerning Support and Service for Persons with Certain Functional Impairments). Humana has approx. 15,000 dedicated employees in Sweden, Norway and Finland who provide care services to more than 8,000 people. We work to achieve the vision “Everyone is entitled to a good life”. In 2017, operating income totalled SEK 6,557 million. Humana has been listed on the Nasdaq Stockholm exchange since 2016 and is headquartered in Stockholm. Learn more about Humana at www.humana.se or http://corporate.humana.se/en.
Tags:
